July 08, 2014

FDA Approves Anacor Pharmaceuticals' KERYDIN™ (Tavaborole) Topical Solution, 5% for the Treatment of Onychomycosis of the Toenails

“I am very excited about the release of this therapy for an infection that is very difficult to treat,” said Boni Elewski, M.D., Vice Chair of Clinical Affairs and Professor of Dermatology at the University of Alabama at Birmingham.

UAB in the News

 
 
Back to Top